Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1327562.RABIp8fO6M9ZA_2Um8v4CDLcKIRH65QMCbJzIQeNZAUlM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1327562.RABIp8fO6M9ZA_2Um8v4CDLcKIRH65QMCbJzIQeNZAUlM130_assertion type Assertion NP1327562.RABIp8fO6M9ZA_2Um8v4CDLcKIRH65QMCbJzIQeNZAUlM130_head.
- NP1327562.RABIp8fO6M9ZA_2Um8v4CDLcKIRH65QMCbJzIQeNZAUlM130_assertion description "[mda-6 was identified using subtraction hybridization by virtue of its enhanced expression in human melanoma cells induced to terminally differentiate by treatment with human fibroblast interferon and the anti-leukemic compound mezerein (Jiang and Fisher, 1993).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1327562.RABIp8fO6M9ZA_2Um8v4CDLcKIRH65QMCbJzIQeNZAUlM130_provenance.
- NP1327562.RABIp8fO6M9ZA_2Um8v4CDLcKIRH65QMCbJzIQeNZAUlM130_assertion evidence source_evidence_literature NP1327562.RABIp8fO6M9ZA_2Um8v4CDLcKIRH65QMCbJzIQeNZAUlM130_provenance.
- NP1327562.RABIp8fO6M9ZA_2Um8v4CDLcKIRH65QMCbJzIQeNZAUlM130_assertion SIO_000772 7936668 NP1327562.RABIp8fO6M9ZA_2Um8v4CDLcKIRH65QMCbJzIQeNZAUlM130_provenance.
- NP1327562.RABIp8fO6M9ZA_2Um8v4CDLcKIRH65QMCbJzIQeNZAUlM130_assertion wasDerivedFrom befree-2016 NP1327562.RABIp8fO6M9ZA_2Um8v4CDLcKIRH65QMCbJzIQeNZAUlM130_provenance.
- NP1327562.RABIp8fO6M9ZA_2Um8v4CDLcKIRH65QMCbJzIQeNZAUlM130_assertion wasGeneratedBy ECO_0000203 NP1327562.RABIp8fO6M9ZA_2Um8v4CDLcKIRH65QMCbJzIQeNZAUlM130_provenance.